Reem Pharmaceutical

Owned or controlled by Muhammad Abd-al-Amir Farhat who is connected to weapons of mass destruction (WMD) and their delivery systems

Status:Top Alert – Entity designated / sanctioned for terror, WMD and human rights violation

Risk Level:99%

May harm your business future. Persons or entities that engage in transactions with this entity will be exposed to sanctions or subject to an enforcement action.

Working with this entity means supporting Iranian Regime, Regime Terrorist Activities & development of WMD

Reem Pharmaceutical is being designated for being owned or controlled by Muhammad Abd-al-Amir Farhat;

Also Known as:
Reem Pharmaceutical, LLC
Reem Pharmaceutical, S.A.R.L.
Reem Pharmaceutical, SAL


Kalim Bechara Building, 2nd floor, Trabolsi Street, Badaro, Beirut, Lebanon



Person of interests:
Muhammad Abd-al-Amir Farhat

Reason for the color:
» Added on February 3, 2017 to the Specially Designated Nationals (SDN) list maintained by the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC), freezing his assets under U.S. jurisdiction and prohibting transactions with U.S. parties, pursuant to Executive Order 13382, which targets proliferators of weapons of mass destruction (WMD) and their delivery systems;